Thermo Fisher Scientific Inc
TMO570.330USD
-5.580-0.97%
Handelsschluss 12/16, 16:00（ET）Kurse um 15 Minuten verzögert
214.28BMarktkapitalisierung
32.91KGV TTM
mehr Informationen über Thermo Fisher Scientific Inc Unternehmen
Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. It also provides purification and filtration technologies.
Thermo Fisher Scientific Inc Informationen
BörsenkürzelTMO
Name des UnternehmensThermo Fisher Scientific Inc
IPO-datumAug 27, 1980
CEOCasper (Marc N)
Anzahl der mitarbeiter125000
WertpapierartOrdinary Share
GeschäftsjahresendeAug 27
Addresse168 Third Avenue
StadtWALTHAM
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl02451
Telefon17816221000
Websitehttps://corporate.thermofisher.com/us/en/index.html
BörsenkürzelTMO
IPO-datumAug 27, 1980
CEOCasper (Marc N)
Führungskräfte von Thermo Fisher Scientific Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Marc N. Casper
Mr. Marc N. Casper
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
112.55K
--
Mr. Michel Lagarde
Mr. Michel Lagarde
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
73.38K
+475.77%
Mr. Scott M. Sperling
Mr. Scott M. Sperling
Lead Independent Director
Lead Independent Director
73.03K
+0.78%
Mr. Stephen Williamson
Mr. Stephen Williamson
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
37.08K
-1.15%
Mr. Michael D. Shafer
Mr. Michael D. Shafer
Executive Vice President
Executive Vice President
18.98K
--
Mr. Nelson J. Chai
Mr. Nelson J. Chai
Independent Director
Independent Director
14.48K
+4.06%
Mr. Gianluca Pettiti
Mr. Gianluca Pettiti
Executive Vice President
Executive Vice President
11.48K
--
Ms. Lisa P. Britt
Ms. Lisa P. Britt
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
10.66K
-20.84%
Mr. Michael A. Boxer
Mr. Michael A. Boxer
Senior Vice President, General Counsel
Senior Vice President, General Counsel
8.87K
-29.85%
Dr. Tyler Jacks
Dr. Tyler Jacks
Director
Director
8.62K
+7.01%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Marc N. Casper
Mr. Marc N. Casper
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
112.55K
--
Mr. Michel Lagarde
Mr. Michel Lagarde
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
73.38K
+475.77%
Mr. Scott M. Sperling
Mr. Scott M. Sperling
Lead Independent Director
Lead Independent Director
73.03K
+0.78%
Mr. Stephen Williamson
Mr. Stephen Williamson
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
37.08K
-1.15%
Mr. Michael D. Shafer
Mr. Michael D. Shafer
Executive Vice President
Executive Vice President
18.98K
--
Mr. Nelson J. Chai
Mr. Nelson J. Chai
Independent Director
Independent Director
14.48K
+4.06%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Consumables
4.61B
42.43%
Service
4.61B
42.42%
Instruments
1.64B
15.15%
Nach RegionUSD
Name
Umsatz
Anteil
North America
5.72B
52.71%
Europe
2.83B
26.07%
Asia Pacific
1.92B
17.69%
Other Regions
383.00M
3.53%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Consumables
4.61B
42.43%
Service
4.61B
42.42%
Instruments
1.64B
15.15%
Aktionärsstatistik
Aktualisiert: Sun, Nov 16
Aktualisiert: Sun, Nov 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
8.96%
BlackRock Institutional Trust Company, N.A.
4.55%
State Street Investment Management (US)
4.36%
Capital World Investors
2.74%
Geode Capital Management, L.L.C.
2.17%
Andere
77.22%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
8.96%
BlackRock Institutional Trust Company, N.A.
4.55%
State Street Investment Management (US)
4.36%
Capital World Investors
2.74%
Geode Capital Management, L.L.C.
2.17%
Andere
77.22%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
50.57%
Investment Advisor/Hedge Fund
30.17%
Pension Fund
2.80%
Bank and Trust
2.73%
Research Firm
2.62%
Hedge Fund
1.91%
Sovereign Wealth Fund
1.86%
Family Office
0.20%
Family Office
0.20%
Andere
6.92%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
4341
344.96M
91.81%
-9.54M
2025Q2
4335
351.93M
93.19%
-4.42M
2025Q1
4395
350.27M
92.78%
-5.82M
2024Q4
4330
349.72M
92.67%
-4.90M
2024Q3
4195
348.49M
91.10%
-6.75M
2024Q2
4169
349.06M
91.37%
-3.26M
2024Q1
4150
346.74M
90.80%
-11.10M
2023Q4
4145
353.49M
91.48%
-3.65M
2023Q3
4035
353.30M
91.43%
-5.83M
2023Q2
4030
357.37M
92.63%
+1.15M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
33.62M
8.9%
+304.63K
+0.91%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
16.94M
4.49%
-335.33K
-1.94%
Jun 30, 2025
State Street Investment Management (US)
16.48M
4.36%
-58.52K
-0.35%
Jun 30, 2025
Capital World Investors
9.58M
2.54%
-1.48M
-13.41%
Jun 30, 2025
Geode Capital Management, L.L.C.
8.11M
2.15%
-12.40K
-0.15%
Jun 30, 2025
Fidelity Management & Research Company LLC
3.22M
0.85%
-727.96K
-18.43%
Jun 30, 2025
T. Rowe Price Associates, Inc.
5.00M
1.32%
-3.74M
-42.82%
Jun 30, 2025
Morgan Stanley Smith Barney LLC
5.61M
1.49%
+1.13M
+25.29%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
5.59M
1.48%
-469.24K
-7.75%
Jun 30, 2025
Putnam Investment Management, L.L.C.
3.35M
0.89%
+55.55K
+1.69%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
VanEck Morningstar Wide Moat Value ETF
5.72%
Goldman Sachs Future Health Care Equity ETF
5.09%
Honeytree US Equity ETF
4.9%
Parnassus Value Select ETF
4.52%
Health Care Select Sector SPDR Fund
4.39%
Proshares Ultra Health Care
4.24%
iShares U.S. Healthcare ETF
4.2%
AdvisorShares Focused Equity ETF
4.01%
GMO US Quality ETF
4%
Brookstone Value Stock ETF
3.97%
Mehr Anzeigen
VanEck Morningstar Wide Moat Value ETF
Anteil5.72%
Goldman Sachs Future Health Care Equity ETF
Anteil5.09%
Honeytree US Equity ETF
Anteil4.9%
Parnassus Value Select ETF
Anteil4.52%
Health Care Select Sector SPDR Fund
Anteil4.39%
Proshares Ultra Health Care
Anteil4.24%
iShares U.S. Healthcare ETF
Anteil4.2%
AdvisorShares Focused Equity ETF
Anteil4.01%
GMO US Quality ETF
Anteil4%
Brookstone Value Stock ETF
Anteil3.97%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
2.29B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Jul 10, 2025
TMO.NB Final Cash Dividend of gross USD 0.43 paid on Oct 15, 2025 going ex on Sep 15, 2025
Sep 15, 2025
Oct 15, 2025
Sep 15, 2025
May 21, 2025
TMO.NB Interim Cash Dividend of gross USD 0.43 paid on Jul 15, 2025 going ex on Jun 13, 2025
Jun 13, 2025
Jul 15, 2025
Jun 13, 2025
Feb 19, 2025
TMO.NB Interim Cash Dividend of gross USD 0.43 paid on Apr 15, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 15, 2025
Mar 14, 2025
Nov 07, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jan 15, 2025 going ex on Dec 13, 2024
Dec 13, 2024
Jan 15, 2025
Dec 13, 2024
Jul 11, 2024
TMO.NB Final Cash Dividend of gross USD 0.39 paid on Oct 15, 2024 going ex on Sep 13, 2024
Sep 13, 2024
Oct 15, 2024
Sep 13, 2024
May 22, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jul 15, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 15, 2024
Jun 14, 2024
Feb 21, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Apr 15, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 15, 2024
Mar 14, 2024
Nov 09, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jan 16, 2024 going ex on Dec 14, 2023
Dec 15, 2023
Jan 16, 2024
Dec 14, 2023
Jul 13, 2023
TMO.NB Final Cash Dividend of gross USD 0.35 paid on Oct 13, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 13, 2023
Sep 14, 2023
May 24, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jul 14, 2023 going ex on Jun 14, 2023
Jun 15, 2023
Jul 14, 2023
Jun 14, 2023
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Thermo Fisher Scientific Inc?
Die fünf größten Anteilseigner von Thermo Fisher Scientific Inc sind:
The Vanguard Group, Inc. hält 33.62M Aktien, was 8.90% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 16.94M Aktien, was 4.49% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 16.48M Aktien, was 4.36% der Gesamtaktien entspricht.
Capital World Investors hält 9.58M Aktien, was 2.54% der Gesamtaktien entspricht.
Geode Capital Management, L.L.C. hält 8.11M Aktien, was 2.15% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 33.62M Aktien, was 8.90% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 16.94M Aktien, was 4.49% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 16.48M Aktien, was 4.36% der Gesamtaktien entspricht.
Capital World Investors hält 9.58M Aktien, was 2.54% der Gesamtaktien entspricht.
Geode Capital Management, L.L.C. hält 8.11M Aktien, was 2.15% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von Thermo Fisher Scientific Inc?
Die drei wichtigsten Anteilseigner-Typen von Thermo Fisher Scientific Inc sind:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
Wie viele Institutionen halten Anteile an Thermo Fisher Scientific Inc (TMO)?
Mit Stand vom 2025Q3 halten 4341 Institutionen Anteile an Thermo Fisher Scientific Inc, mit einem Gesamtmarktwert von etwa 344.96M, was 91.81% der Gesamtanteile entspricht. Im Vergleich zum 2025Q2 ist der institutionelle Aktienbesitz um -1.39% gestiegen.
Was ist die größte Einnahmequelle von Thermo Fisher Scientific Inc?
Am FY2025Q2 erzielte das Geschäft mit Consumables für Thermo Fisher Scientific Inc den höchsten Umsatz in Höhe von 4.61B, was 42.43% des Gesamtumsatzes entspricht.
